HomeRCKT • NASDAQ
add
Rocket Pharmaceuticals Inc
Previous close
$3.42
Day range
$3.11 - $3.37
Year range
$2.19 - $14.78
Market cap
341.98M USD
Avg Volume
2.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 52.42M | -24.49% |
Net income | -50.33M | 24.56% |
Net profit margin | — | — |
Earnings per share | -0.45 | 36.24% |
EBITDA | -49.18M | 26.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 222.76M | -5.48% |
Total assets | 368.03M | -6.52% |
Total liabilities | 54.36M | -14.95% |
Total equity | 313.67M | — |
Shares outstanding | 108.22M | — |
Price to book | 1.18 | — |
Return on assets | -33.22% | — |
Return on capital | -36.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -50.33M | 24.56% |
Cash from operations | -50.42M | 3.23% |
Cash from investing | 93.62M | 18.62% |
Cash from financing | -67.00K | -138.07% |
Net change in cash | 43.13M | 59.78% |
Free cash flow | -31.51M | -47.07% |
About
Founded
1999
Headquarters
Website
Employees
299
